Moderna (MRNA) Change in Taxes (2021 - 2024)

Moderna (MRNA) has 4 years of Change in Taxes data on file, last reported at -$2.0 million in Q3 2024.

• On a quarterly basis, Change in Taxes fell 122.22% year-over-year to -$2.0 million in Q3 2024; TTM through Sep 2024 was -$51.0 million, a 410.0% decrease from a year earlier, with the FY2023 full-year figure at $15.0 million, up 101.81% from the prior year.
• Change in Taxes for Q3 2024 stood at -$2.0 million, up from -$45.0 million in the prior quarter.
• Over the last five years, Change in Taxes for MRNA reached as high as $716.0 million in Q1 2022 and fell as low as -$1.2 billion in Q2 2022.
• Historically, Change in Taxes has averaged $333333.3 across 4 years, with a median of $7.0 million in 2023.
• On a YoY basis, Change in Taxes climbed as much as 695.56% in 2022 and fell as far as 533.1% in 2022.
• Year by year, Change in Taxes stood at $311.0 million in 2021, then tumbled by 105.79% to -$18.0 million in 2022, then surged by 138.89% to $7.0 million in 2023, then slumped by 128.57% to -$2.0 million in 2024.
• Per Business Quant data, the three most recent Change in Taxes figures were -$2.0 million in Q3 2024, -$45.0 million in Q2 2024, and -$11.0 million in Q1 2024.